Join
Live feed
·
INSIDERFilingvia Quantisnow
Stoke Therapeutics Inc. logo

Interim Executive Chair Tzianabos Arthur exercised 3,955 shares at a strike of $8.33 and sold $174,214 worth of shares (4,355 units at $40.00), decreasing direct ownership by 1% to 31,339 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track STOK (Stoke Therapeutics Inc.) and more on Quantisnow.